Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma.

Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma. Clin Cancer Res. 2023 04 03; 29(7):1200-1208.

View in: PubMed